JournalsHub
.online
Find My Journal
PD

Patricia DeArbeloa

Independent Researcher

ORCID 0000-0002-6597-9104
14
Publications
689
Citations
5
H-Index
4
i10-Index
5.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
Michael J. Pishvaian, Edik M. Blais, Jonathan R. Brody, Emily E. Lyons, Patricia DeArbeloa +11 more
The Lancet Oncology 2020
528
A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients OA
Michael J. Pishvaian, Edik M. Blais, R Joseph Bender, Shruti Rao, Simina M. Boca +14 more
JAMIA Open 2019
84
Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature OA
Medhavi Gupta, Christopher Sherrow, Maghan E. Krone, Edik M. Blais, Michael J. Pishvaian +12 more
Journal of the National Comprehensive Cancer Network 2021
49
Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC): Clinical/molecular correlations and real-world outcomes across standard therapies.
Andrew Hendifar, Edik M. Blais, Camille Ng, Dzung Thach, Jun Gong +12 more
Journal of Clinical Oncology 2020
15
Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database OA
Abrahm Levi, Edik M. Blais, John Davelaar, Matthew Ebia, Angela Minasyan +13 more
The Oncologist 2025
5

Publications

14 total

Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database PDF

Abrahm Levi, Edik M. Blais, John Davelaar, Matthew Ebia, Angela Minasyan et al. - The Oncologist, 2025
Cited by 5 OpenAlex

Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy

Ida Micaily, Edik M. Blais, Randi Zukas Carhart, Sophia Lam, Steven J. Cohen et al. - JCO Precision Oncology, 2023
Cited by 4 OpenAlex

Validation of the PDACai signature in predicting relative benefit from frontline FOLFIRINOX (FFX) and gemcitabine/nab-paclitaxel (GA) for patients (pts) with metastatic pancreatic cancer (mPDAC).

Michael J. Pishvaian, Edik M. Blais, Dzung Thach, Jonathan R. Brody, Lynn M. Matrisian et al. - Journal of Clinical Oncology, 2023
Cited by 0 OpenAlex

Real-world use of PARP inhibitors in BRCA1/2-mutated pancreatic cancer: A retrospective analysis.

Suvina Amin, Weiyan Li, Seongjung Joo, Gboyega Adeboyeje, Patricia DeArbeloa et al. - Journal of Clinical Oncology, 2022
Cited by 2 OpenAlex

Real-world clinical outcomes and molecular features of lung-specific and liver-specific metastases in pancreatic ductal adenocarcinoma (PDAC).

Arsen Osipov, Edik M. Blais, John Davelaar, Natalie Moshayedi, Nima Nikravesh et al. - Journal of Clinical Oncology, 2022
Cited by 1 OpenAlex

Real-world timelines of BRCA1/2-related molecular testing in pancreatic cancer.

Weiyan Li, Suvina Amin, Seongjung Joo, Gboyega Adeboyeje, Patricia DeArbeloa et al. - Journal of Clinical Oncology, 2022
Cited by 0 OpenAlex

Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature PDF

Medhavi Gupta, Christopher Sherrow, Maghan E. Krone, Edik M. Blais, Michael J. Pishvaian et al. - Journal of the National Comprehensive Cancer Network, 2021
Cited by 49 OpenAlex

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial

Michael J. Pishvaian, Edik M. Blais, Jonathan R. Brody, Emily E. Lyons, Patricia DeArbeloa et al. - The Lancet Oncology, 2020
Cited by 528 OpenAlex

Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC): Clinical/molecular correlations and real-world outcomes across standard therapies.

Andrew Hendifar, Edik M. Blais, Camille Ng, Dzung Thach, Jun Gong et al. - Journal of Clinical Oncology, 2020
Cited by 15 OpenAlex

Real-world outcomes in pancreatic adenocarcinoma (PDAC) and persona types with implications for standard of care (SOC) therapy (Tx).

Emanuel F. Petricoin, Michael J. Pishvaian, Patricia DeArbeloa, Daniel Barg, Dzung Thach et al. - Journal of Clinical Oncology, 2020
Cited by 0 OpenAlex

Research Topics

Cancer Genomics and Diagnostics (13) Pancreatic and Hepatic Oncology Research (10) Renal cell carcinoma treatment (3) Neuroendocrine Tumor Research Advances (2) Colorectal Cancer Treatments and Studies (2)

Frequent Co-Authors

MI
Michael J. Pishvaian
13 joint publications
ED
Edik M. Blais
13 joint publications
LY
Lynn M. Matrisian
10 joint publications
EM
Emanuel F. Petricoin
9 joint publications
AN
Andrew Hendifar
8 joint publications
JO
Jonathan R. Brody
6 joint publications

Affiliations

Xperi (Ireland)
IE 2019 - 2019

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now